Rheonix is a biotech company that develops automated molecular testing solutions.

Rheonix, Inc. is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often.

Rheonix was founded in 2007 by Gregory J. Galvin and is based in Ithaca, New York, United States.

Rheonix's EncompassMDx instrument includes standard equipment, such as a liquid handler with disposable pipette tips, bulk reagent packages, drive components for 4 Rheonix CARD consumables, a thermal cycler, hybridization heaters, a barcode reader, an imager, and a PC.

Rheonix, through experienced leadership and creative vision, has developed the Encompass platform, a highly customizable technology with unmatched versatility and affordability. The platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD® cartridge.




  • Year founded: 2007
  • Funding Info: $86.7M in 7 funding rounds (Last funding type: Venture - Series Unknown)
  • Yearly Revenue: $10M-$15M (2018)
  • Employee Size: 51-200
  • Business Valuation: Unknown
  • City/Town: Ithaca
  • State: New York
  • Country: United States
Related businesses